Clinical trial Recruiting at 1 site Interventional Ages 21 to 85

Using an optical sensor to monitor blood pressure at the fingertip

Official title: Recording of Physiological Data Via an Optical Sensor At the Fingertip Alongside with Double Auscultatory and Pulse Oximetry to Evaluate the Effectiveness of an Optical Blood Pressure Monitoring (OBPM) Algorithm That Requires No Calibration with an External Cuff: a Single-center Prospective Clinical Study

Run by Aktiia SA · NCT06368206 · Data updated 2026-11-12

This study is testing a new device that measures blood pressure at the fingertip to see how well it works for different people.

More Hypertension trials

Quick facts

Study typeInterventional
Ages21 Years to 85 Years
SexAll
Enrollment85 (estimated)
SponsorAktiia SA
Industry-sponsored
Locations1 site (Lausanne)
StatusRecruiting
StartedJune 25, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedDecember 17, 2024
Trial IDNCT06368206 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 21 to 85 who are fluent in French and can commit to the study procedures.

Probably not a fit

Patients with conditions that affect peripheral perfusion or those with certain cardiac arrhythmias may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of an optical blood pressure monitoring device by collecting raw optical data from participants using the Aktiia G2C system. A minimum of 85 participants will be involved in a single visit lasting about one hour, during which various reference systems will be used for comparison. The study will include individuals with diverse phenotypes to assess the device's performance across different populations.

Why it matters

Potential benefit: If successful, this study could lead to a more accurate and non-invasive method for monitoring blood pressure in patients.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in non-invasive blood pressure monitoring techniques.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects aged 21 to 85yo
* Subjects fluent in written and spoken French
* Subjects agreeing to attend the study visit and follow study procedures
* Subjects that have signed the informed consent form.

Exclusion Criteria:

* Amputated index fingers
* Damaged/injured skin at index fingers
* Damaged/injured skin at wrists
* Subjects suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including tachycardia (heart rate at rest \> 120bpm) and atrial fibrillation
* Subjects suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL/min/1.73 m2), hyper-/hypothyroidism, pheochromocytoma or arteriovenous fistula
* Pregnant women
* Polyneuropathy

Where it's running

  • Chuv
    Lausanne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.